Results 241 to 250 of about 6,383,361 (296)
70 Years of DON and Beyond: Glutaminase Inhibition as a Synergistic Strategy in Cancer Combination Therapy. [PDF]
PharmaceuticsCampos-Sandoval JA +3 more
europepmc +1 more source
Quantitative systems pharmacology modeling of class I-III BRAF-mutant NSCLC enables subgroup treatment analysis and combination therapy design. [PDF]
iScienceHu J +7 more
europepmc +1 more source
Combination therapy of carbon dioxide laser with topical halometason cream and 308 nm excimer laser for the treatment of vitiligo: an optimized combined treatment protocol. [PDF]
Lasers Med SciYang Y +6 more
europepmc +1 more source
Lorlatinib monotherapy or combination therapy in anaplastic lymphoma kinase-driven high-risk neuroblastoma. [PDF]
NPJ Precis OncolXie W +10 more
europepmc +1 more source
Juniperus phoenicea extract-loaded nanostructured lipid carriers for potent antimicrobial and anticancer combination therapy. [PDF]
AMB ExpressIsmail PA +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Respiratory Care Clinics of North America, 2001
Although not allowing one to state conclusively that a particular combination of approaches to CMV and adjuncts to CMV affect outcome, the results are encouraging. Independently, none of the modalities discussed-HFV, ECMO, NO, or PLV-have shown a statistically significant improvement in outcome except NO.
openaire +2 more sources
Although not allowing one to state conclusively that a particular combination of approaches to CMV and adjuncts to CMV affect outcome, the results are encouraging. Independently, none of the modalities discussed-HFV, ECMO, NO, or PLV-have shown a statistically significant improvement in outcome except NO.
openaire +2 more sources
Neurological Sciences, 2006
So far, off-label recommendation of a combination therapy is mainly based on phase II study evidence and on largely accepted expert opinions. Combination therapy represents a new, more global strategy, to increase the possible benefits with the combined use of already available disease-modifying therapies or with other new agents, having an acceptable ...
openaire +3 more sources
So far, off-label recommendation of a combination therapy is mainly based on phase II study evidence and on largely accepted expert opinions. Combination therapy represents a new, more global strategy, to increase the possible benefits with the combined use of already available disease-modifying therapies or with other new agents, having an acceptable ...
openaire +3 more sources